We are live on ! Find out more
BLACU

Bellevue Life Sciences Acquisition Corp. Unit

Delisted

BLACU was delisted on the 14th of February, 2025.

10 hedge funds and large institutions have $7.63M invested in Bellevue Life Sciences Acquisition Corp. Unit in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% less funds holding

Funds holding: 1310 (-3)

58% less capital invested

Capital invested by funds: $18.1M → $7.63M (-$10.5M)

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
10
Holders Change
-3
Holders Change %
-23.08%
% of All Funds
0.16%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
1
Closed
4
Calls
Puts
Net Calls
Net Calls Change

BLACU Hedge Fund Activity: Q3 2023 in Review

10 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Bellevue Life Sciences Acquisition Corp. Unit (BLACU) for Q3 2023, worth a combined $7.63M — down 58% from $18.1M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of BLACU and 1 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 0 added.

The largest buyer was Clear Street, opening a new position worth an estimated $63.5K. The largest seller was Periscope Capital, exiting entirely with an estimated $6.33M sold.

  • 10 institutional investors held Bellevue Life Sciences Acquisition Corp. Unit (BLACU) as of Q3 2023, down from 13 in Q2 2023.
  • Funds reported $7.63M of Bellevue Life Sciences Acquisition Corp. Unit stock for Q3 2023, down 58% quarter-over-quarter.
  • 1 fund opened new Bellevue Life Sciences Acquisition Corp. Unit positions in Q3 2023 and 4 closed out, a net change of -3 holders.
  • The largest Bellevue Life Sciences Acquisition Corp. Unit buyer in Q3 2023 was Clear Street, an estimated $63.5K added.
  • The largest Bellevue Life Sciences Acquisition Corp. Unit seller in Q3 2023 was Periscope Capital, an estimated $6.33M sold.

Based on aggregated 13F filings for Q3 2023.